Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Exchange Rate Effect (2019 - 2023)

AVITA Medical's Exchange Rate Effect history spans 5 years, with the latest figure at -$1000.0 for Q4 2023.

  • For Q4 2023, Exchange Rate Effect fell 102.27% year-over-year to -$1000.0; the TTM value through Dec 2023 reached -$16000.0, up 57.89%, while the annual FY2023 figure was -$16000.0, 38.46% up from the prior year.
  • Exchange Rate Effect reached -$1000.0 in Q4 2023 per RCEL's latest filing, up from -$18000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $127000.0 in Q3 2020 to a low of -$68000.0 in Q1 2020.
  • Average Exchange Rate Effect over 5 years is $5062.5, with a median of -$3500.0 recorded in 2022.
  • Peak YoY movement for Exchange Rate Effect: soared 677.27% in 2020, then plummeted 143.31% in 2021.
  • A 5-year view of Exchange Rate Effect shows it stood at $48000.0 in 2019, then tumbled by 35.42% to $31000.0 in 2020, then tumbled by 277.42% to -$55000.0 in 2021, then soared by 180.0% to $44000.0 in 2022, then plummeted by 102.27% to -$1000.0 in 2023.
  • Per Business Quant, the three most recent readings for RCEL's Exchange Rate Effect are -$1000.0 (Q4 2023), -$18000.0 (Q3 2023), and $2000.0 (Q2 2023).